Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Lopalco

Showing results (81-90 of 221) with videos related to

Pageof 23
Sort By:
Autoimmunity Reviews|August 26, 2014
Effectiveness and tuberculosis-related safety profile of interleukin-1 blocking agents in the management of Behçet's diseaseLuca Cantarini, Giuseppe Lopalco, Francesco Caso, et al.
Ophthalmology and Therapy|March 25, 2026
Irreversible Ocular and Systemic Damage in ROSAH SyndromeClaudia Fabiani, Valeria Caggiano, Jessica Sbalchiero, et al.
The Israel Medical Association Journal : IMAJ|August 9, 2017
Intravitreal Dexamethasone Implant as an Adjunct Weapon for Severe and Refractory Uveitis in Behçet's DiseaseClaudia Fabiani, Giacomo Emmi, Giuseppe Lopalco, et al.
Hepatology (Baltimore, Md.)|January 24, 2015
Safety of long-term biologic therapy in rheumatologic patients with a previously resolved hepatitis B viral infectionMichele Barone, Antonella Notarnicola, Giuseppe Lopalco, et al.
Mediators of Inflammation|October 30, 2020
Real-Life Data on the Efficacy of Canakinumab in Patients with Adult-Onset Still's DiseaseAntonio Vitale, Virginia Berlengiero, Jurgen Sota, et al.
International Journal of Rheumatic Diseases|August 19, 2015
Safety profile of biologic agents for Behçet's disease in a multicenter observational cohort studyLuca Cantarini, Rosaria Talarico, Elena Generali, et al.
Clinical and Experimental Rheumatology|November 8, 2019
Efficacy of monoclonal anti-tumour necrosis factor-α antibodies in uveitic macular oedemaGian Marco Tosi, Antonio Vitale, Donato Rigante, et al.
Clinical and Experimental Rheumatology|December 16, 2016
Long-term safety of anti-TNF agents on the liver of patients with spondyloarthritis and potential occult hepatitis B viral infection: an observational multicentre studyChiara Giannitti, Giuseppe Lopalco, Antonio Vitale, et al.
Internal and Emergency Medicine|February 2, 2020
Behçet's syndrome in Italy: a detailed retrospective analysis of 396 cases seen in 3 tertiary referral clinicsJurgen Sota, Donato Rigante, Giacomo Emmi, et al.
Internal and Emergency Medicine|November 11, 2025
Sjögren's disease and concomitant fibromyalgia: clinical profile and implications for disease activity assessmentStefano Stano, Vincenzo Venerito, Daniele Domanico, et al.
Pageof 23

Showing results (81-90 of 221) with videos related to

Sort By:
Pageof 23
Autoimmunity Reviews|August 26, 2014
Effectiveness and tuberculosis-related safety profile of interleukin-1 blocking agents in the management of Behçet's diseaseLuca Cantarini, Giuseppe Lopalco, Francesco Caso, et al.
Ophthalmology and Therapy|March 25, 2026
Irreversible Ocular and Systemic Damage in ROSAH SyndromeClaudia Fabiani, Valeria Caggiano, Jessica Sbalchiero, et al.
The Israel Medical Association Journal : IMAJ|August 9, 2017
Intravitreal Dexamethasone Implant as an Adjunct Weapon for Severe and Refractory Uveitis in Behçet's DiseaseClaudia Fabiani, Giacomo Emmi, Giuseppe Lopalco, et al.
Hepatology (Baltimore, Md.)|January 24, 2015
Safety of long-term biologic therapy in rheumatologic patients with a previously resolved hepatitis B viral infectionMichele Barone, Antonella Notarnicola, Giuseppe Lopalco, et al.
Mediators of Inflammation|October 30, 2020
Real-Life Data on the Efficacy of Canakinumab in Patients with Adult-Onset Still's DiseaseAntonio Vitale, Virginia Berlengiero, Jurgen Sota, et al.
International Journal of Rheumatic Diseases|August 19, 2015
Safety profile of biologic agents for Behçet's disease in a multicenter observational cohort studyLuca Cantarini, Rosaria Talarico, Elena Generali, et al.
Clinical and Experimental Rheumatology|November 8, 2019
Efficacy of monoclonal anti-tumour necrosis factor-α antibodies in uveitic macular oedemaGian Marco Tosi, Antonio Vitale, Donato Rigante, et al.
Clinical and Experimental Rheumatology|December 16, 2016
Long-term safety of anti-TNF agents on the liver of patients with spondyloarthritis and potential occult hepatitis B viral infection: an observational multicentre studyChiara Giannitti, Giuseppe Lopalco, Antonio Vitale, et al.
Internal and Emergency Medicine|February 2, 2020
Behçet's syndrome in Italy: a detailed retrospective analysis of 396 cases seen in 3 tertiary referral clinicsJurgen Sota, Donato Rigante, Giacomo Emmi, et al.
Internal and Emergency Medicine|November 11, 2025
Sjögren's disease and concomitant fibromyalgia: clinical profile and implications for disease activity assessmentStefano Stano, Vincenzo Venerito, Daniele Domanico, et al.
Pageof 23